首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Investigation on effects of the nourishing kidney and eliminating toxicity decoction on immunological imbalance of Th1, Th17 and Treg in HBV transgenic mice
【24h】

Investigation on effects of the nourishing kidney and eliminating toxicity decoction on immunological imbalance of Th1, Th17 and Treg in HBV transgenic mice

机译:补肾祛毒汤对HBV转基因小鼠Th1,Th17和Treg免疫失衡影响的研究

获取原文
       

摘要

Objective: To study the immune mechanism of nourishing kidney and eliminating toxicity decoction (NKETD) on Chronic Hepatitis B (CHB), we detected the serum concentrations of IFN-γ (the characteristic cytokine of Th1), IL-17A (the characteristic cytokine of Th17) and the quantitative proportion of CDsup+/supsub4/subCDsup+/supsub25/sub foxp3 Treg to CDsup+/supsub4/sub Treg in HBV transgenic mice. Methods: The HBV transgenic mice were randomly divided into six groups: high-dose group, middle-dose group, low-dose group, lamivudine group, model control group and normal mice control group. The serum concentrations of IFN-γ and IL-17A in mice were measured by ELISA method and the ratio of CDsup+/supsub4/subCDsup+/supsub25/sub foxp3 Treg to CDsup+/supsub4/sub Treg was detected by Flow Cytometry Method (FCM). Results: The decoction could increase the serum concentration of IFN-γ and decrease that of IL-17A in HBV transgenic mice. The higher the dose was, the more significantly the concentration of IFN-γ increased. And high-dose decoction could decrease the serum concentration of IL-17A in HBV transgenic mice significantly and continuously while middle-dose and low-dose decoction had no significant effects. However, there wasn’t statistically significant variation on the ratio of CDsup+/supsub4/subCDsup+/supsub25/sub foxp3 Treg to CDsup+/supsub4/sub Treg in HBV transgenic mice. Conclusion: The decoction could treat CHB by regulating the immune function by promoting the generation of Th1 and/or enhancing its function while inhibiting Th17. The immune regulation by decoction had more significant effects than lamivudine.
机译:目的:研究补肾除毒汤对慢性乙型肝炎(CHB)的免疫机制,检测其血清中IFN-α的含量。 (Th1的特征性细胞因子),IL-17A(Th17的特征性细胞因子)和CD + 4 CD + < HBV转基因小鼠中将sub> 25 foxp3 Treg转化为CD + 4 Treg。方法:将HBV转基因小鼠随机分为六组:高剂量组,中剂量组,低剂量组,拉米夫定组,模型对照组和正常小鼠对照组。 IFN-γ的血清浓度; ELISA法测定小鼠体内的IL-17A和IL-17A,CD + 4 CD + 25 foxp3的比例用流式细胞术(FCM)检测Treg对CD + 4 的Treg。结果:煎剂可提高血清IFN-γ的浓度。降低了HBV转基因小鼠的IL-17A水平。剂量越高,IFN-γ的浓度越显着。增加。高剂量水煎剂能显着,连续降低HBV转基因小鼠血清IL-17A的浓度,而中,低剂量水煎剂无明显作用。但是,CD + 4 CD + 25 foxp3的比率没有统计学上的显着变化HBV转基因小鼠中Treg对CD + 4 Treg的影响。结论:该汤可通过促进Th1的产生和/或增强其功能同时抑制Th17来调节免疫功能,从而治疗CHB。煎剂的免疫调节作用比拉米夫定更显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号